Unknown

Dataset Information

0

ChIP-seq of pancreatic cancer cells derived from a genetically engineered mouse model, which harbor the inducible KrasG12D allele


ABSTRACT: Pancreatic adenocarcinoma (PDAC) is a lethal disease and it is the most common type of pancreatic cancer. Majority of the pancreatic cancers harbor alterations in the Kras gene. Currently there are no approved drugs that target Kras directly and it's downstream effect on the epigenome remains unknown. In this study, we investigated the epigenetic landscape of pancreatic cancer cells which harbor the inducible KrasG12D allele. We performed RNA-seq, ChIP-seq against 6 different histone marks, ATAC-seq and RRBS to assess the changes in the epigenome after oncogenic KrasG12D induction.

SUBMITTER: Romica Kerketta 

PROVIDER: E-MTAB-10901 | BioStudies | 2021-09-06

SECONDARY ACCESSION(S): ERP131503

REPOSITORIES: biostudies

Similar Datasets

2021-09-06 | E-MTAB-10901 | ArrayExpress
2021-09-19 | E-MTAB-10909 | ArrayExpress
1000-01-01 | S-EPMC4347237 | BioStudies
1000-01-01 | S-EPMC5071541 | BioStudies
2010-01-01 | S-EPMC3141286 | BioStudies
2019-01-01 | S-EPMC6888344 | BioStudies
2020-01-01 | S-EPMC7545986 | BioStudies
2020-01-01 | S-EPMC7125138 | BioStudies
2020-01-01 | S-EPMC6954322 | BioStudies
2020-01-06 | E-MTAB-8467 | BioStudies